PLoS ONE (Jan 2011)

Modulation of the CD95-induced apoptosis: the role of CD95 N-glycosylation.

  • Olga M Shatnyeva,
  • Andriy V Kubarenko,
  • Claudia E M Weber,
  • Alexander Pappa,
  • Reinhard Schwartz-Albiez,
  • Alexander N R Weber,
  • Peter H Krammer,
  • Inna N Lavrik

DOI
https://doi.org/10.1371/journal.pone.0019927
Journal volume & issue
Vol. 6, no. 5
p. e19927

Abstract

Read online

Protein modifications of death receptor pathways play a central role in the regulation of apoptosis. It has been demonstrated that O-glycosylation of TRAIL-receptor (R) is essential for sensitivity and resistance towards TRAIL-mediated apoptosis. In this study we ask whether and how glycosylation of CD95 (Fas/APO-1), another death receptor, influences DISC formation and procaspase-8 activation at the CD95 DISC and thereby the onset of apoptosis. We concentrated on N-glycostructure since O-glycosylation of CD95 was not found. We applied different approaches to analyze the role of CD95 N-glycosylation on the signal transduction: in silico modeling of CD95 DISC, generation of CD95 glycosylation mutants (at N136 and N118), modulation of N-glycosylation by deoxymannojirimycin (DMM) and sialidase from Vibrio cholerae (VCN). We demonstrate that N-deglycosylation of CD95 does not block DISC formation and results only in the reduction of the procaspase-8 activation at the DISC. These findings are important for the better understanding of CD95 apoptosis regulation and reveal differences between apoptotic signaling pathways of the TRAIL and CD95 systems.